<SEC-DOCUMENT>0001104659-23-047802-index.html : 20230420
<SEC-HEADER>0001104659-23-047802.hdr.sgml : 20230420
<ACCEPTANCE-DATETIME>20230420163240
ACCESSION NUMBER:		0001104659-23-047802
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20230420
DATE AS OF CHANGE:		20230420

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
		CENTRAL INDEX KEY:			0001621227
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271145
		FILM NUMBER:		23833553

	BUSINESS ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX
		BUSINESS PHONE:		44 1235 430000

	MAIL ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptimmune Ltd
		DATE OF NAME CHANGE:	20141001
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>tm239007-7_424b3.htm
<DESCRIPTION>424B3
<TEXT>
Document 1 - file: tm239007-7_424b3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_adaptimmune-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: lg_adaptimmune-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lg_tcr-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: lg_tcr-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lg_pipersandler-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: lg_pipersandler-4c.jpg

</DOCUMENT>
</SEC-DOCUMENT>